scholarly article | Q13442814 |
P356 | DOI | 10.1002/LT.23831 |
P698 | PubMed publication ID | 24477986 |
P50 | author | Bong-Soo Cha | Q61196432 |
Myoung Soo Kim | Q84974983 | ||
Yongin Cho | Q85778587 | ||
Eun Seok Kang | Q59703034 | ||
P2093 | author name string | Dong Jin Joo | |
Min Jung Lee | |||
Chang Hee Jung | |||
Joong-Yeol Park | |||
Eun Yeong Choe | |||
P2860 | cites work | Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials | Q29622947 |
Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study | Q33937741 | ||
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis | Q34027392 | ||
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial | Q34293369 | ||
Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity | Q34426367 | ||
Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial | Q34847163 | ||
Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes | Q35855311 | ||
Transplanted liver: consequences of denervation for liver functions | Q35894480 | ||
Mitochondrial dysfunction in white adipose tissue | Q36198938 | ||
Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up. | Q36696738 | ||
New onset diabetes mellitus after solid organ transplantation | Q36993705 | ||
Mitochondrial dysfunction in pancreatic beta-cells in Type 2 diabetes | Q37209210 | ||
Management of cardiovascular risk: the importance of meeting lipid targets | Q38018650 | ||
New-onset diabetes mellitus: predictive factors and impact on the outcome of patients undergoing liver transplantation | Q38043070 | ||
Do statins cause diabetes? | Q38086101 | ||
Adult-to-adult living donor liver transplantation at the Asan Medical Center, Korea. | Q38521548 | ||
Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic beta-cells | Q39965445 | ||
Post-renal transplant diabetes mellitus in korean subjects: superimposition of transplant-related immunosuppressant factors on genetic and type 2 diabetic risk factors | Q42209549 | ||
Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database | Q42656443 | ||
The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation | Q42686323 | ||
Association of common type 2 diabetes risk gene variants and posttransplantation diabetes mellitus in renal allograft recipients in Korea. | Q43278824 | ||
Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality | Q43752482 | ||
Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients | Q44051171 | ||
Diabetes, hypertension and hyperlipidemia: prevalence over time and impact on long-term survival after liver transplantation | Q44195066 | ||
New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. | Q44789148 | ||
Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. | Q45962265 | ||
New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation | Q46480478 | ||
Predictive factors for posttransplant diabetes mellitus within one-year of liver transplantation | Q46580991 | ||
Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus | Q46645985 | ||
New-onset diabetes after liver transplantation | Q46719525 | ||
Weight change and obesity after liver transplantation: incidence and risk factors | Q47286068 | ||
Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. | Q51466759 | ||
Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients. | Q51476761 | ||
Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection : an observational multicenter study. | Q51482450 | ||
A Polymorphism in the Zinc Transporter Gene SLC30A8 Confers Resistance Against Posttransplantation Diabetes Mellitus in Renal Allograft Recipients | Q57500079 | ||
P433 | issue | 5 | |
P921 | main subject | statin therapy | Q62562875 |
P304 | page(s) | 557-563 | |
P577 | publication date | 2014-02-25 | |
P1433 | published in | Liver Transplantation | Q15730498 |
P1476 | title | Statin therapy is associated with the development of new-onset diabetes after transplantation in liver recipients with high fasting plasma glucose levels | |
P478 | volume | 20 |
Q90601583 | Incidence of Recurrent NASH-Related Allograft Cirrhosis |
Q38543105 | Non-alcoholic fatty liver disease following liver transplantation: a clinical review. |
Q39004220 | Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation |
Q53755580 | Pharmacometabolomic signature links simvastatin therapy and insulin resistance. |
Q50145783 | Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment |
Q36541052 | Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes |
Q37205087 | Prevalence, predictive factors, and survival outcome of new-onset diabetes after liver transplantation: A population-based cohort study. |
Q61799108 | Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients |
Q52607836 | Statins and New-Onset Diabetes in Cardiovascular and Kidney Disease Cohorts: A Meta-Analysis. |
Search more.